Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study.

Gulhan, Ibrahim; Bozkaya, Giray; Bilgir, Ferda; Kebapcilar, Levent; Bilgir, Oktay; Kavrut, Mustecep; Dogan, ÖMER

doi:10.3109/09513590.2010.502273

Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study.

Gulhan I., Bozkaya G., Bilgir F., Kebapcilar L., Bilgir O., Kavrut M., ...Daha Fazla

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.27, sa.8, ss.568-71, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 27 Sayı: 8
Basım Tarihi: 2011
Doi Numarası: 10.3109/09513590.2010.502273
Dergi Adı: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.568-71
Anahtar Kelimeler: Premature ovarian failure, homocysteine, asymmetric dimethylarginine
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. Objective. To investigate serum homocysteine and asymmetric dimethylarginine (ADMA) levels in patients with premature ovarian failure (POF).